BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26686626)

  • 21. Transcriptome-wide mapping reveals reversible and dynamic N(1)-methyladenosine methylome.
    Li X; Xiong X; Wang K; Wang L; Shu X; Ma S; Yi C
    Nat Chem Biol; 2016 May; 12(5):311-6. PubMed ID: 26863410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway.
    Carbonneau M; M Gagné L; Lalonde ME; Germain MA; Motorina A; Guiot MC; Secco B; Vincent EE; Tumber A; Hulea L; Bergeman J; Oppermann U; Jones RG; Laplante M; Topisirovic I; Petrecca K; Huot MÉ; Mallette FA
    Nat Commun; 2016 Sep; 7():12700. PubMed ID: 27624942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromothripsis and Kataegis Induced by Telomere Crisis.
    Maciejowski J; Li Y; Bosco N; Campbell PJ; de Lange T
    Cell; 2015 Dec; 163(7):1641-54. PubMed ID: 26687355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.
    Lu Y; Kwintkiewicz J; Liu Y; Tech K; Frady LN; Su YT; Bautista W; Moon SI; MacDonald J; Ewend MG; Gilbert MR; Yang C; Wu J
    Cancer Res; 2017 Apr; 77(7):1709-1718. PubMed ID: 28202508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer.
    Clark O; Yen K; Mellinghoff IK
    Clin Cancer Res; 2016 Apr; 22(8):1837-42. PubMed ID: 26819452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Registered report: IDH mutation impairs histone demethylation and results in a block to cell differentiation.
    Richarson AD; Scott DA; Zagnitko O; Aza-Blanc P; Chang CC; Russler-Germain DA;
    Elife; 2016 Mar; 5():e10860. PubMed ID: 26971564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CNS cancer: Breaking boundaries - IDH mutations in glioma.
    Killock D
    Nat Rev Clin Oncol; 2016 Feb; 13(2):64. PubMed ID: 26787277
    [No Abstract]   [Full Text] [Related]  

  • 28. Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas.
    Ikemura M; Shibahara J; Mukasa A; Takayanagi S; Aihara K; Saito N; Aburatani H; Fukayama M
    Histopathology; 2016 Aug; 69(2):260-7. PubMed ID: 26741321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes.
    Tran TQ; Ishak Gabra MB; Lowman XH; Yang Y; Reid MA; Pan M; O'Connor TR; Kong M
    PLoS Biol; 2017 Nov; 15(11):e2002810. PubMed ID: 29107960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates.
    Ye D; Guan KL; Xiong Y
    Trends Cancer; 2018 Feb; 4(2):151-165. PubMed ID: 29458964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhein Inhibits AlkB Repair Enzymes and Sensitizes Cells to Methylated DNA Damage.
    Li Q; Huang Y; Liu X; Gan J; Chen H; Yang CG
    J Biol Chem; 2016 May; 291(21):11083-93. PubMed ID: 27015802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker.
    Beharry AA; Lacoste S; O'Connor TR; Kool ET
    J Am Chem Soc; 2016 Mar; 138(11):3647-50. PubMed ID: 26967262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.
    Wang G; Lu X; Dey P; Deng P; Wu CC; Jiang S; Fang Z; Zhao K; Konaparthi R; Hua S; Zhang J; Li-Ning-Tapia EM; Kapoor A; Wu CJ; Patel NB; Guo Z; Ramamoorthy V; Tieu TN; Heffernan T; Zhao D; Shang X; Khadka S; Hou P; Hu B; Jin EJ; Yao W; Pan X; Ding Z; Shi Y; Li L; Chang Q; Troncoso P; Logothetis CJ; McArthur MJ; Chin L; Wang YA; DePinho RA
    Cancer Discov; 2016 Jan; 6(1):80-95. PubMed ID: 26701088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Hydroxykynurenine toxicity on the rat striatum in vivo.
    Nakagami Y; Saito H; Katsuki H
    Jpn J Pharmacol; 1996 Jun; 71(2):183-6. PubMed ID: 8835646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological Role and Therapeutic Potential of IDH Mutations in Cancer.
    Waitkus MS; Diplas BH; Yan H
    Cancer Cell; 2018 Aug; 34(2):186-195. PubMed ID: 29805076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncometabolites suppress DNA repair by disrupting local chromatin signalling.
    Sulkowski PL; Oeck S; Dow J; Economos NG; Mirfakhraie L; Liu Y; Noronha K; Bao X; Li J; Shuch BM; King MC; Bindra RS; Glazer PM
    Nature; 2020 Jun; 582(7813):586-591. PubMed ID: 32494005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.
    Inoue S; Li WY; Tseng A; Beerman I; Elia AJ; Bendall SC; Lemonnier F; Kron KJ; Cescon DW; Hao Z; Lind EF; Takayama N; Planello AC; Shen SY; Shih AH; Larsen DM; Li Q; Snow BE; Wakeham A; Haight J; Gorrini C; Bassi C; Thu KL; Murakami K; Elford AR; Ueda T; Straley K; Yen KE; Melino G; Cimmino L; Aifantis I; Levine RL; De Carvalho DD; Lupien M; Rossi DJ; Nolan GP; Cairns RA; Mak TW
    Cancer Cell; 2016 Aug; 30(2):337-348. PubMed ID: 27424808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m
    Su R; Dong L; Li C; Nachtergaele S; Wunderlich M; Qing Y; Deng X; Wang Y; Weng X; Hu C; Yu M; Skibbe J; Dai Q; Zou D; Wu T; Yu K; Weng H; Huang H; Ferchen K; Qin X; Zhang B; Qi J; Sasaki AT; Plas DR; Bradner JE; Wei M; Marcucci G; Jiang X; Mulloy JC; Jin J; He C; Chen J
    Cell; 2018 Jan; 172(1-2):90-105.e23. PubMed ID: 29249359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma.
    McBrayer SK; Mayers JR; DiNatale GJ; Shi DD; Khanal J; Chakraborty AA; Sarosiek KA; Briggs KJ; Robbins AK; Sewastianik T; Shareef SJ; Olenchock BA; Parker SJ; Tateishi K; Spinelli JB; Islam M; Haigis MC; Looper RE; Ligon KL; Bernstein BE; Carrasco RD; Cahill DP; Asara JM; Metallo CM; Yennawar NH; Vander Heiden MG; Kaelin WG
    Cell; 2018 Sep; 175(1):101-116.e25. PubMed ID: 30220459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies.
    Madala HR; Punganuru SR; Arutla V; Misra S; Thomas TJ; Srivenugopal KS
    Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29439493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.